There is a vision currently being researched in mosquito laboratories; the possibility that it may be possible to release mosquitoes containing some genetic factor that would drive through wild populations and disable their capacity to transmit disease. Not likely you say?
Yesterday I gave a talk for the Dialogues house in Amsterdam, which is affiliated to the ABN-AMRO Bank. The audience consisted of people that have no background or experience in malaria. But something funny happened there...
As part of the TH!NK3 blogging competition 'Developing World', I wrote an article last week titled 'The man who saved Brazil'. It was the 11th article I wrote for this endeavour, and I see it as my most important one till now. It is the one I sincerely hope you will read. And let me know how you feel about it.
University Research Co, LLC is implementing a USAID-funded program in Benin, West Africa. An important component of the program focuses on improving malaria mortality and morbidity. Specific objectives include improvement of malaria case management, improved intermittent preventive treatment for pregnant women, supply chain management, and monitoring and evaluation.
What do data analysis and hitting mules in the head with a board have in common? Too much. Ouch!
Today a new forum topic was launched by Drs Derek Charlwood and Erling Pedersen from DBL in Copenhagen. They argue that pyrethroids should no longer be used for indoor residual spraying and be reserved for use on bednets. What's your opinion?
Every so often a book appears about malaria. About its history, great discoveries, and the historic and current battle against it. But sometimes there's a book that goes the extra mile by providing a critical outside view on what we all try to accomplish. This is what you get when reading 'The Fever: How malaria has ruled humankind for 500,000 years', written by Sonia Shah.
Applications are invited for a Postdoctoral Research scientist to work on a project funded by the FCT (National Scientific Foundation), Portugal to investigate the role of immune stimulatory molecules on mosquito Anopheles gambiae response against the malaria parasite Plasmodium berghei (PTDC/SAU-MII/102596/2008).
In many countries in Africa, sustained control efforts which had reduced the number of infected people in a population to near zero, were suddenly overcome by explosive epidemics. This happened in Garki Nigeria in the 1970's, and again in central Sudan in the 1980's.
This may seem a ridiculous question. With 280 million people diseased every year, and 850.000 deaths, how can one argue that malaria is not important?
The current enthusiasm for malaria control in Africa will bring us much closer to our goal if we build on the successes of the past, and avoid repeating the mistakes. The major mistake in the global Malaria Eradication Program of 1955 was to embark on an unsustainable strategy, which collapsed within a decade. We need to ensure that current strategies do not repeat this mistake.
Dr. Dondorp is the Deputy Director and Head of malaria research at the Mahidol-Oxford Research Unit in Bangkok, Thailand, where he plans, coordinates and supervises clinical and laboratory malaria studies.
'TH!NK3: Developing world' is the third round of the European Journalism Centre's widely acclaimed international blogging competition series. The participants of TH!NK3 (called "TH!NKers") are journalism students, academics and experts from 27 EU Member States, neighbourhood countries and beyond.
Objectors to applications in public health assert that because it is impossible to obtain informed consent that the technology is inadequate. What a remarkable conclusion!
These days, not only scientists are debating about the existence and potential impact of climate change. Since the mishaps in the fourth assessment report of the IPCC were revealed and received enormous media exposure, even my parents in law (non-scientists) have been asking me about it. Now I wonder when my 3-year old daughter will start casting doubts…
In the early 1990s, when scientists first came up with a radical new idea to engineer mosquitoes that would no longer be capable of transmitting pathogens, some thought of an even more fantastic application. Use mosquitoes to vaccinate people. Silence followed until now...
Dr. Corbel is currently a senior researcher at IRD, and based at the CREC in Cotonou in Benin. Following five years of heading the WHO collaborating centre for the evaluation of new public health pesticides he moved to Benin where he undertakes highly interesting studies aimed at improving vector control across Africa.
Now that we're reaching the end of the first decade in which the world focused on the Millenium Development Goals, it is time to look both back and forward. Several competitions have been set up to get both amateur and professional journalists interested in writing about the failures and successes so far, including malaria. But the Guardian has a special way of doing this...
Raphael N’Guessan is a Medical Entomologist and West Africa IVCC programme manager based in Benin. His current research interests are on malaria vector control, with particular emphasis on control of resistant vectors, insecticide resistance management, and investigation of alternative strategies for its delay.
Q: Dear Raphael, please tell us what the main focus of your work is, and why this is important within the framework of malaria control and elimination.
There is great historical and practical value in looking at the successful attack on malaria in Italy during the past century, and then going ahead to plan for the attack on malaria in Africa during this century.
Dr. Gunilla Priebe recently graduated from the University of Gothenburg (Sweden) on a most interesting topic. She advocates further Africanisation of malaria research based on her study of the Multilateral Initiative on Malaria. Some questions for Gunilla...
Question/Bart: If you argue for more research in the South, then what should the role of scientists in the North be(come)?...
“If the malaria control program(s) I manage receives 5% of its current funds 5 years from now, would the maximum level of transmission reduction we have achieved during that time be maintained 5 years later?”
E-interviews are a new section on MalariaWorld, where we interview members about their work and role in the field of malaria. This is our first e-interview, with Mr. Fredros Okumu, working at the Ifakara Health Institute in Tanzania and PhD student at the London School of Hygiene and Tropical Medicine.
Last week, Nathan Myhrvold, a former Microsoft executive, presented a fascinating new invention to the world during a talk at the TED conference. The TED talks are renowned for providing a stage for great people with great ideas...
Speaking at TED means a lot of global attention, and Myhrvold played his cards right. With a display of the invention that uses laser technology to shoot down mosquitoes on the wing, and some stunning video footage, it was certain that the global press would jump on the story. Hundreds of websites and facebook pages covered this breakthrough, that was twittered to hundreds of thousands of people around the planet. Intellectual Ventures, the company headed by Myhrvold, has done well this week.
Interestingly, although the world may think this is a new invention, it is not. The Wall Street Journal ran an article on the same invention on 14 March 2009. Back then the video footage wasn't as exciting, leading to limited press attention. But why did Myhrvold not use the last ten months to demonstrate the potential of his invention in the real world, in a rural setting somewhere in Africa?
On 18 January I flew from Amsterdam to Copenhagen for a 3-day workshop on malaria and architecture. The KLM Fokker 100 took off in time at 07.05 am, and nothing eventful happened until the time I opened the in-flight magazine Holland Herald…
The London School of Hygiene & Tropical Medicine invites applications for Three PhD studentships in the Department of Infectious and Tropical Diseases.
Seattle Biomedical Research Institute is actively recruiting a high energy Project Manager for Dr. Kappe’s scientific programs, including GAP vaccine research and clinical trials.
The James Gang at UC Irvine has made a useful contribution to the question of whether or not transgenic mosquitoes are fit.
In the Lancet of 5 February 1910 I discovered a most interesting little article about malaria on Antigua island (Carribean)...
There is a good reason for putting out a large variety of products with similar function on the market – like cars. It simply has to do with our innate differences in preference with regard to colour, shape, make, etc. Some like a blue car, others a white or a red one. And, suprise surprise, the great level of differentation means that almost everyone can find a car that matches his/her preferences at an affordable price....